Supreme Court Criticizes High Markups on Essential Cancer Drug Prices
The Supreme Court expressed strong concern over the significant overpricing of essential cancer medicines, highlighting a case where a drug's maximum retail price (MRP) was Rs 27,000 despite being supplied to retailers at Rs 2,700. The bench described this as "broad daylight dacoity" and extortion, questioning the silence of regulatory authorities. The court is hearing petitions seeking stricter price controls and generic prescription mandates, with further hearings scheduled for September 29.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is negative (30/100). Lens Score 68/100.
Outlets measured: timesnow, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (28–38/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 22 Sept, 01:01 pm. Other outlets followed.
- 1